ASHLEY BEVAK: Open Payments
NPI 1619353174 · BROOKVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,089 in 122 payments from 27 companies in 2025. Trend: 2023 $1,717 · 2024 $1,796 · 2025 $2,089
Food & beverage: $2,079Education: $10
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $233 |
| Amgen Inc. | 16 | $214 |
| Novo Nordisk Inc | 14 | $211 |
| AstraZeneca Pharmaceuticals LP | 9 | $186 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $148 |
| Lilly USA, LLC | 8 | $139 |
| Phathom Pharmaceuticals, Inc. | 5 | $107 |
| ABBVIE INC. | 4 | $82 |
| Exact Sciences Corporation | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $65 |
Products named: JARDIANCE, FARXIGA, Ozempic, VOQUEZNA, OTEZLA, MOUNJARO, NURTEC ODT, PREVNAR 20.
Industry payments across PA — which companies pay providers there.
